Dalbavancin

Chemical formula: C₈₈H₁₀₀Cl₂N₁₀O₂₈  Molecular mass: 1,814.609 g/mol  PubChem compound: 23724878

Therapeutic indications

Dalbavancin is indicated for:

Acute bacterial skin and skin structure infections (ABSSSI)

Population group: only adults (18 - 65 years old)

Dalbavancin is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: XYDALBA Powder for concentrate for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈